Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 12-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | 67,229 | 11,226 |
| Receivables | N/A | 35,500 | 5,927 |
| Inventories | N/A | 58,000 | 2,137 |
| TOTAL | $N/A | $160,729 | $19,290 |
| Non-Current Assets | |||
| PPE Net | N/A | 4,362 | 1,846 |
| Other Non-Current Assets | 0 | 384,072 | 60,446 |
| TOTAL | $N/A | $388,434 | $62,292 |
| Total Assets | $N/A | $527,096 | $80,834 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 76,596 | 12,043 |
| Other current liabilities | N/A | 23,618 | 0 |
| TOTAL | $N/A | $102,226 | $12,043 |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | 81,610 | 19,011 |
| Other Non-Current Liabilities | 0 | 204,280 | 47,316 |
| TOTAL | $N/A | $304,811 | $72,488 |
| Total Liabilities | $N/A | $395,263 | $84,531 |
| Shareholders' Equity | |||
| Common Shares | N/A | 11,918 | 25,198 |
| Retained earnings | N/A | -131,137 | -72,263 |
| Other shareholders' equity | 0 | 248,630 | -24,865 |
| TOTAL | $N/A | $131,833 | $-3,697 |
| Total Liabilities And Equity | $0 | $527,096 | $80,834 |